Pancreatic cancer has long carried one of the darkest reputations in oncology. Often called the “silent killer,” it rarely produces clear symptoms in its early stages, leaving most patients diagnosed only when the disease has already advanced. As a result, global five-year survival rates remain stubbornly low, hovering around 10%. Now, a breakthrough from China…